Literature DB >> 8418785

Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care.

C P Page1, J M Bohnen, J R Fletcher, A T McManus, J S Solomkin, D H Wittmann.   

Abstract

Prophylactic administration of antibiotics can decrease postoperative morbidity, shorten hospitalization, and reduce the overall costs attributable to infections. Principles of prophylaxis include providing effective levels of antibiotics in the decisive interval, and, in most instances, limiting the course to intraoperative coverage only. Use in The National Research Council clean contaminated operations is appropriate and, in many instances, has been proven beneficial. Antibiotic prophylaxis is also indicated for clean operations, such as those involved with insertion of prosthetic devices, that are associated with low infection risk and high morbidity. Extension of antibiotic prophylaxis to other categories of clean wounds should be limited to patients with two or more risk factors established by criteria in the study of the efficacy of nosocomial infection control (SENIC) because the baseline infection rate in these patients is high enough to justify their use. Cefazolin (or cefoxitin when anaerobic coverage is necessary) remains the mainstay of prophylactic therapy. Selection of an alternate agent should be based on specific contraindications, local infection control surveillance data, and the results of clinical trials. Newer criteria for determining the risk of "site infection" (wound and intracavitary) are in evolution and may lead to modification of these recommendations over the next several years.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418785     DOI: 10.1001/archsurg.1993.01420130087014

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  67 in total

Review 1.  Antimicrobial prophylaxis.

Authors:  J Smith; A Finn
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 2.  Preventing postoperative infections: current treatment recommendations.

Authors:  I C Gyssens
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

Review 3.  Cost-effective prophylaxis of surgical infections.

Authors:  S R Norrby
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

4.  Prevention of post-coccygectomy infection in a series of 136 coccygectomies.

Authors:  Levon Doursounian; Jean-Yves Maigne; Bertrand Cherrier; Jerome Pacanowski
Journal:  Int Orthop       Date:  2010-06-10       Impact factor: 3.075

Review 5.  Elective inguinal hernia repair with mesh: is there a need for antibiotic prophylaxis?--A review.

Authors:  Seema Biswas
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

6.  Preoperative antibiotics and mortality in the elderly.

Authors:  Jeffrey H Silber; Paul R Rosenbaum; Martha E Trudeau; Wei Chen; Xuemei Zhang; Scott A Lorch; Rachel Rapaport Kelz; Rachel E Mosher; Orit Even-Shoshan
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

Review 7.  [Current perioperative antibiotic prophylaxis].

Authors:  P Kujath; R Bouchard; J Scheele; H Esnaashari
Journal:  Chirurg       Date:  2006-06       Impact factor: 0.955

8.  Influence of bactibilia after preoperative biliary stenting on postoperative infectious complications.

Authors:  Thomas J Howard; Jian Yu; Ryan B Greene; Virgilio George; George M Wairiuko; Seth A Moore; James A Madura
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

9.  Exploring obstacles to proper timing of prophylactic antibiotics for surgical site infections.

Authors:  J A Tan; V N Naik; L Lingard
Journal:  Qual Saf Health Care       Date:  2006-02

10.  The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology.

Authors:  Jolyn S Taylor; Claire A Marten; Mark F Munsell; Charlotte C Sun; Kimberly A Potts; Jennifer K Burzawa; Alpa M Nick; Larissa A Meyer; Keith Myers; Diane C Bodurka; Thomas A Aloia; Charles F Levenback; David R Lairson; Kathleen M Schmeler
Journal:  Ann Surg Oncol       Date:  2016-08-29       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.